乐胖代购免代理版

{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T13:42:22Z","timestamp":1740145342109,"version":"3.37.3"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T00:00:00Z","timestamp":1662681600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T00:00:00Z","timestamp":1662681600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Austrian Science Foundation","award":["P31400-N32"]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cent Eur J Oper Res"],"published-print":{"date-parts":[[2023,6]]},"abstract":"Abstract<\/jats:title>Optimal distribution of vaccines to achieve high population immunity levels is a desirable aim in infectious disease epidemiology. A distributed optimal control epidemiological model that accounts for vaccination was developed and applied to the case of the COVID-19 pandemic. The model proposed here is nonstandard and takes into account the heterogeneity of the infected sub-population with respect to the time since infection, which is essential in the case of COVID-19. Based on the epidemiological characteristics of COVID-19 we analyze several vaccination scenarios and an optimal vaccination policy. In particular we consider random vaccination over the whole population and the prioritization of age groups such as the elderly and compare the effects with the optimal solution. Numerical results of the model show that random vaccination is efficient in reducing the overall number of infected individuals. Prioritization of the elderly leads to lower mortality though. The optimal strategy in terms of total deaths is early prioritization of those groups having the highest contact rates. \n<\/jats:p>","DOI":"10.1007\/s10100-022-00819-z","type":"journal-article","created":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T07:04:41Z","timestamp":1662707081000},"page":"499-521","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Optimal vaccination strategies using a distributed model applied to COVID-19"],"prefix":"10.1007","volume":"31","author":[{"given":"Georgi","family":"Angelov","sequence":"first","affiliation":[]},{"given":"Raimund","family":"Kovacevic","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3808-265X","authenticated-orcid":false,"given":"Nikolaos I.","family":"Stilianakis","sequence":"additional","affiliation":[]},{"given":"Vladimir M.","family":"Veliov","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2022,9,9]]},"reference":[{"key":"819_CR1","unstructured":"Acemoglu D, Chernozhukov V, Werning I, Whinston MD (2000) Optimal targeted lockdowns in a multi-group SIR model. National Bureau of Economic Research, Working Paper 27102, May, 2000. URL http:\/\/www.nber.org\/papers\/w27102"},{"issue":"4","key":"819_CR2","doi-asserted-by":"publisher","DOI":"10.1098\/rsos.160097","volume":"3","author":"K Bhattacharaya","year":"2016","unstructured":"Bhattacharaya K, Ghosh A, Monsivais D, Dunbar RIM, Kaski K (2016) Sex differences in social focus across the life cycle in humans. Royal Society Open Science 3(4):160097","journal-title":"Royal Society Open Science"},{"key":"819_CR3","unstructured":"Bloom DE, Kuhn M, Prettner K (2000) Modern infectious diseases: macroeconomic impacts and policy responses. PGDA Working Paper No. 187, August, 2000. URL http:\/\/www.hsph.harvard.edu\/pgda\/working\/"},{"key":"819_CR4","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1126\/science.abe6959","volume":"371","author":"K Bubar","year":"2021","unstructured":"Bubar K, Reinhold K, Kissler SM, Lipsitch M, Cobey S, Grad YH, Larremore DB (2021) Model-informed COVID-19 vaccine prioritization strategies by age and serostatus. Science 371:916\u2013921. https:\/\/doi.org\/10.1126\/science.abe6959","journal-title":"Science"},{"key":"819_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmateco.2021.102489","volume":"93","author":"JP Caulkins","year":"2021","unstructured":"Caulkins JP, Grass D, Feichtinger G, Hartl RF, Kort PM, Prskawetz A, Seidl A, Wrzaczek S (2021) The optimal lockdown intensity for COVID-19. J Math Econ 93:102489. https:\/\/doi.org\/10.1016\/j.jmateco.2021.102489","journal-title":"J Math Econ"},{"key":"819_CR6","doi-asserted-by":"crossref","unstructured":"Davis NG, Klepac P, Liu Y, Prem K, Jit M, CMMID COVID-19 working group, Eggo RM, (2020) Age-dependent effects in the transmission and control of COVID-19 epidemics Nat. Med. 26:1205\u20131211","DOI":"10.1038\/s41591-020-0962-9"},{"issue":"8","key":"819_CR7","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/S1473-3099(21)00057-8","volume":"21","author":"PC Jentsch","year":"2021","unstructured":"Jentsch PC, Anand M, Bauch CT (2021) Prioritising COVID-19 vaccination in changing social and epidemiological landscapes: a mathematical modelling study. Lancet Infect Dis 21(8):1097\u20131106. https:\/\/doi.org\/10.1016\/S1473-3099(21)00057-8","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"819_CR8","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.35057","volume":"4","author":"MA Johansson","year":"2021","unstructured":"Johansson MA, Quandelacy TM, Kada S, Vemkanda Prasad P, Steel M, Brooks JT, Slayton RB, Biggerstaff M, Butler JC (2021) SARS-CoV-2 transmission from people without COVID-19 symptoms. JAMA Netw Open 4(1):e2035057","journal-title":"JAMA Netw Open"},{"issue":"2","key":"819_CR9","doi-asserted-by":"publisher","first-page":"S221","DOI":"10.1137\/20M1373840","volume":"60","author":"RM Kovacevic","year":"2022","unstructured":"Kovacevic RM, Stilianakis NI, Veliov VM (2022) A distributed optimal control model applied to COVID-19 pandemic. SIAM J Control Opt 60(2):S221\u2013S245","journal-title":"SIAM J Control Opt"},{"key":"819_CR10","doi-asserted-by":"publisher","first-page":"eabf1374","DOI":"10.1126\/sciadv.abf1374","volume":"7","author":"L Matrajt","year":"2021","unstructured":"Matrajt L, Eaton J, Leung T, Brown ER (2021) Vaccine optimization for COVID-19: Who to vaccinate first? Sci Adv 7:eabf1374. https:\/\/doi.org\/10.1126\/sciadv.abf1374","journal-title":"Sci Adv"},{"issue":"6","key":"819_CR11","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1016\/S1473-3099(21)00143-2","volume":"21","author":"S Moore","year":"2021","unstructured":"Moore S, Hill EM, Tildeslay MJ, Dyson L, Keeling MJ (2021) Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study. Lancet Infect Dis 21(6):793\u2013802","journal-title":"Lancet Infect Dis"},{"key":"819_CR12","first-page":"1775","volume":"323","author":"G Onder","year":"2020","unstructured":"Onder G, Rezza G, Brusaferro S (2020) Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA 323:1775\u20131776","journal-title":"JAMA"},{"key":"819_CR13","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1007\/s00038-020-01486-0","volume":"65","author":"C Signorelli","year":"2020","unstructured":"Signorelli C, Odone A (2020) Age-specific COVID-19 case-fatality rate: no evidence of changes over time. Int J Public Health 65:1435\u20131436","journal-title":"Int J Public Health"},{"key":"819_CR14","unstructured":"Statistics Austria. Bev\u00f6lkerung zu Jahresbeginn 2002-2020 nach f\u00fcnfj\u00e4hrigen Altersgruppen und Geschlecht. https:\/\/www.statistik.at\/web_de\/statistiken\/menschen_und_gesellschaft\/~bevoelkerung\/bevoelkerungsstruktur\/bevoelkerung_nach_alter_geschlecht\/index.html"},{"key":"819_CR15","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S1473-3099(20)30243-7","volume":"20","author":"R Verity","year":"2020","unstructured":"Verity R, Okell LC, Dorigatti I, Winskill P, Whittaker C, Imai N et al (2020) Estimates of the severity of coronavirus disease 2019: A model-based analysis. Lancet Infect Dis 20:669\u2013677","journal-title":"Lancet Infect Dis"},{"key":"819_CR16","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","volume":"180","author":"C Wu","year":"2020","unstructured":"Wu C, Chen X, Cai Y, Xia J, Zhou X, Xu S et al (2020) Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan. China JAMA Intern Med 180:934\u2013943","journal-title":"China JAMA Intern Med"}],"container-title":["Central European Journal of Operations Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10100-022-00819-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10100-022-00819-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10100-022-00819-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T09:24:35Z","timestamp":1679390675000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10100-022-00819-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,9]]},"references-count":16,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["819"],"URL":"https:\/\/doi.org\/10.1007\/s10100-022-00819-z","relation":{},"ISSN":["1435-246X","1613-9178"],"issn-type":[{"type":"print","value":"1435-246X"},{"type":"electronic","value":"1613-9178"}],"subject":[],"published":{"date-parts":[[2022,9,9]]},"assertion":[{"value":"30 August 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The views expressed are purely those of the writer (NIS) and may not in any circumstance be regarded as stating an official position of the European Commission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}]}}